EVALUATION OF ANTIMICROBIAL RESISTANCE AND MOLECULAR CHARACTERIZATION STAPHYLOCOCCUS AUREUS IN SEPTIC PATIENTS
Main Article Content
Keywords
Staphylococcus aureus; Sepsis; Antimicrobial Resistance; Molecular Characterization.
Abstract
Staphylococcus aureus (S. aureus) is a common pathogen responsible for a wide range of infections. Understanding its characteristics, antimicrobial resistance patterns, and genetic diversity is crucial for effectively managing and controlling infections. This study aimed to assess the genetic and antimicrobial resistance profiles of S. aureus isolates and provide insights into their epidemiology and clinical implications. 100 samples were collected from patients in a hospital setting, and S. aureus isolates were obtained using standard microbiological procedures. The selected patients were screened at Khwaja Fareed University of Engineering & Information Technology (KFUEIT), and data were collected from the patients. Morphological characterization, including colony and cell morphology, was performed. Biochemical tests were conducted to characterize the isolates further. Antimicrobial susceptibility testing was conducted using the disc diffusion method. Molecular characterization was done through DNA extraction and PCR amplification of specific gene targets. The SPSS version 26 was used to evaluate and examine the data. In the polymerase chain reaction (PCR) results, it was found that out of the total 89 samples tested, 42 samples (47.2%) tested positive, while 47 samples (52.7%) tested negative. Age of patients was 53.18±8.98 years. Among patients 45(56.6%) were male, 44(49.4%) were female. The most frequent etiology was diabetes mellitus, accounting for 22.5% of the cases. Hepatic disorders were the second most common etiology, accounting for 20.2% of the cases. Among the septic patients in the study, 51.7% (46 patients) were classified as having primary sepsis, while 48.3% (43 patients) had secondary sepsis. The mean colony appearance week was calculated to be 17.98 ± 13.19 weeks. The frequency of positive results for each test was 89, representing 100% of the total samples tested. The mean MIC value was 13.04 g/Ml. This study conclude the phenotypic and genotypic characteristics of S. aureus isolates and their antimicrobial resistance profiles.
References
2. Agoro, H., & Whitney, T. (2025). Antimicrobial Resistance in Pseudomonas aeruginosa: Implications for Sepsis Management and Public Health.
3. Arshad, S., & Misumida, N. (2021). Rapid Development of Methicillin-Resistant Staphylococcus aureus (MRSA) Purulent Pericarditis in the Setting of Endocarditis. CJC open, 3(12), 1505-1508.
4. Ayala, O. D., Wakeman, C. A., Pence, I. J., Gaddy, J. A., Slaughter, J. C., Skaar, E. P., & Mahadevan-Jansen, A. (2018). Drug-resistant Staphylococcus aureus strains reveal distinct biochemical features with Raman microspectroscopy. ACS Infectious Diseases, 4(8), 1197-1210.
5. De Backer, D., Aldecoa, C., Njimi, H., & Vincent, J.-L. (2012). Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis. Critical care medicine, 40(3), 725-730.
6. Dendani Chadi, Z., & Arcangioli, M.-A. (2023). Pulsed-field gel electrophoresis analysis of bovine associated Staphylococcus aureus: a review. Pathogens, 12(7), 966.
7. Dong, H., Cao, H., & Zheng, H. (2017). Pathogenic bacteria distributions and drug resistance analysis in 96 cases of neonatal sepsis. BMC pediatrics, 17, 1-6.
8. Gandara, A., Mota, L. C., Flores, C., Perez, H. R., Green, C. F., & Gibbs, S. G. (2006). Isolation of Staphylococcus aureus and antibiotic-resistant Staphylococcus aureus from residential indoor bioaerosols. Environmental Health Perspectives, 114(12), 1859-1864.
9. Garg, V., Garg, H., Khan, A., Trehanpati, N., Kumar, A., Sharma, B. C., Sakhuja, P., & Sarin, S. K. (2012). Granulocyte colony–stimulating factor mobilizes CD34+ cells and improves survival of patients with acute-on-chronic liver failure. Gastroenterology, 142(3), 505-512. e501.
10. Huse, H., Miller, S., Chandrasekaran, S., Hindler, J., Lawhon, S., Bemis, D., Westblade, L., & Humphries, R. (2018). Evaluation of oxacillin and cefoxitin disk diffusion and MIC breakpoints established by the clinical and laboratory standards institute for detection of mecA-mediated oxacillin resistance in Staphylococcus schleiferi. Journal of clinical microbiology, 56(2), e01653-01617.
11. Jalali, H. R., Pourbakhsh, A., Fallah, F., & Eslami, G. (2015). Genotyping of virulence factors of uropathogenic Escherichia coli by PCR. Novelty in Biomedicine, 3(4), 177-181.
12. Jasmin, R., Balagangatharathilagar, M., Edith, R., Chandrasekar, M., & Jayathangaraj, M. (2023). Hematological alterations in canine sepsis.
13. Jin, G., Wang, S., Chen, J., Hu, W., Zhu, Y., & Xi, S. (2022). Identification of sepsis-associated encephalopathy risk factors in elderly patients: A retrospective observational cohort study. Turkish Journal of Medical Sciences, 52(5), 1513-1522.
14. Kedarisetty, C. K., Anand, L., Bhardwaj, A., Bhadoria, A. S., Kumar, G., Vyas, A. K., David, P., Trehanpati, N., Rastogi, A., & Bihari, C. (2015). Combination of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrhosis. Gastroenterology, 148(7), 1362-1370. e1367.
15. Kumar, N. R., Balraj, T. A., Kempegowda, S. N., & Prashant, A. (2024). Multidrug-resistant sepsis: A critical healthcare challenge. Antibiotics, 13(1), 46.
16. Lakbar, I., Einav, S., Lalevée, N., Martin-Loeches, I., Pastene, B., & Leone, M. (2023). Interactions between Gender and Sepsis—Implications for the Future. Microorganisms, 11(3), 746.
17. Li, Y.-T., Yu, C.-B., Huang, J.-R., Qin, Z.-J., & Li, L.-J. (2015). Pathogen profile and drug resistance analysis of spontaneous peritonitis in cirrhotic patients. World Journal of Gastroenterology: WJG, 21(36), 10409.
18. Mirsab, W. (2023). Whole genome analysis of Escherichia coli and Staphylococcus aureus isolated from foods of animal origin Indian Veterinary Research Institute].
19. Mu, S., Xiang, H., Wang, Y., Wei, W., Long, X., Han, Y., Kuang, Z., Yang, Y., Xu, F., & Xue, M. (2022). The pathogens of secondary infection in septic patients share a similar genotype to those that predominate in the gut. Critical Care, 26(1), 1-15.
20. Pletz, M. W., Wellinghausen, N., & Welte, T. (2011). Will polymerase chain reaction (PCR)-based diagnostics improve outcome in septic patients? A clinical view. Intensive care medicine, 37, 1069-1076.
21. Póvoa, P., Coelho, L., Dal-Pizzol, F., Ferrer, R., Huttner, A., Conway Morris, A., Nobre, V., Ramirez, P., Rouze, A., & Salluh, J. (2023). How to use biomarkers of infection or sepsis at the bedside: guide to clinicians. Intensive care medicine, 49(2), 142-153.
22. Pradipta, I. S., Sodik, D. C., Lestari, K., Parwati, I., Halimah, E., Diantini, A., & Abdulah, R. (2013). Antibiotic resistance in sepsis patients: evaluation and recommendation of antibiotic use. North American journal of medical sciences, 5(6), 344.
23. Rasquel-Oliveira, F. S., Ribeiro, J. M., Martelossi-Cebinelli, G., Costa, F. B., Nakazato, G., Casagrande, R., & Verri, W. A. (2025). Staphylococcus aureus in inflammation and pain: update on pathologic mechanisms. Pathogens, 14(2), 185.
24. Schreiber, J., Nierhaus, A., Braune, S., Heer, G. d., & Kluge, S. (2013). Comparison of three different commercial PCR assays for the detection of pathogens in critically ill sepsis patients. Medizinische Klinik-Intensivmedizin und Notfallmedizin, 4(108), 311-318.
25. Schuurman, A. R., Sloot, P. M., Wiersinga, W. J., & van der Poll, T. (2023). Embracing complexity in sepsis. Critical Care, 27(1), 102.
26. Sha, Y., Han, G., Hong, Y., Wu, J., Tang, M., Zhu, Y., Zhou, L., & Ni, J. (2023). Distinct lesion features and underlying mechanisms in patients with acute multiple infarcts in multiple cerebral territories. Frontiers in Neurology, 13, 1102505.
27. Silva-de-Jesus, A. C., Ferrari, R. G., Panzenhagen, P., Dos Santos, A. M., Portes, A. B., & Conte-Junior, C. A. (2025). Distribution of Antimicrobial Resistance and Biofilm Production Genes in the Genomic Sequences of S. aureus: A Global In Silico Analysis. Antibiotics, 14(4), 364.
28. Skalec, T., Adamik, B., Kobylinska, K., & Gozdzik, W. (2022). Soluble urokinase-type plasminogen activator receptor levels as a predictor of kidney replacement therapy in septic patients with acute kidney injury: an observational study. Journal of Clinical Medicine, 11(6), 1717.
29. Song, K.-H., Kim, H. B., Kim, H.-s., Lee, M. J., Jung, Y., Kim, G., Hwang, J.-H., Kim, N.-H., Kim, M., & Kim, C.-J. (2015). Impact of area under the concentration–time curve to minimum inhibitory concentration ratio on vancomycin treatment outcomes in methicillin-resistant Staphylococcus aureus bacteraemia. International journal of antimicrobial agents, 46(6), 689-695.
30. Subbarayudu, S., Namasivayam, S. K. R., & Arockiaraj, J. (2024). Immunomodulation in non-traditional therapies for methicillin-resistant Staphylococcus aureus (MRSA) management. Current Microbiology, 81(10), 346.
31. Sugianli, A. K., & Parwati, I. (2020). Laboratory Diagnostic Approach and Interpretation in Gram-Negative Bacterial Infection: A-Case Report of Sepsis in Secondary Hospital Settings. Indonesian Journal of Clinical Pathology and Medical Laboratory, 26(3).
32. Sun, R., Huang, J., Yang, Y., Liu, L., Shao, Y., Li, L., & Sun, B. (2022). Dysfunction of low-density neutrophils in peripheral circulation in patients with sepsis. Scientific reports, 12(1), 685.
33. Tocut, M., Kolitz, T., Shovman, O., Haviv, Y., Boaz, M., Laviel, S., Debi, S., Nama, M., Akria, A., & Shoenfeld, Y. (2022). Outcomes of ICU patients treated with intravenous immunoglobulin for sepsis or autoimmune diseases. Autoimmunity Reviews, 103205.
34. Urrechaga, E. (2020). Reviewing the value of leukocytes cell population data (CPD) in the management of sepsis. Annals of Translational Medicine, 8(15).
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Rabia Iqbal
Department of Biochemistry and Biotechnology, University of Gujrat, 50700 Gujrat, Pakistan.
Naila Ashraf
Master of Philosophy in Biotechnology, The University of Lahore, Lahore, Pakistan.
Fareeha Naz
Pharm D, Masters in Public Health at Lahore College for Women University, Lahore, Pakistan.
Ammar Yasin
BDS at Nishtar Institute of Dentistry, Multan, Pakistan.
Tayyaba Yasin
Institute of Molecular Biology and Biotechnology at The University of Lahore, Lahore, Pakistan.
Sana Ijaz
Institute of Molecular Biology and Biotechnology at The University of Lahore, Lahore, Pakistan.